BR-931

Known as: BR 931 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1978-1991
01219781991

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Previous studies have demonstrated that BR-931, a hepatic peroxisome proliferator, can induce liver tumours in mice and rats… (More)
  • figure 1
  • table I
  • table II
  • figure 2
Is this relevant?
1989
1989
Hypolipidemic drugs and certain plasticizers markedly increase the number of peroxisomes in liver parenchymal cells. Continued… (More)
Is this relevant?
1986
1986
The potent peroxisome proliferator hepatocarcinogens WY-14,643, BR-931, and nafenopin, as well as mono(ethylhexyl)phthalate (MEHP… (More)
Is this relevant?
1984
1984
The peroxisome proliferators Wy-14,643, BR-931, nafenopin and ciprofibrate were tested in the primary hepatocyte culture… (More)
Is this relevant?
1984
1984
A study was conducted of the effects of 10 hypolipidaemic agents on peroxisomal and microsomal enzyme activities in primary… (More)
Is this relevant?
1983
1983
Primary cultures of rat hepatocytes were exposed to a range of chemicals known to cause peroxisome proliferation in vivo… (More)
Is this relevant?
1981
1981
The hypolipidaemic drugs methyl clofenapate, BR-931, Wy-14643 and procetofen induced a marked proliferation of peroxisomes in the… (More)
Is this relevant?
Highly Cited
1980
Highly Cited
1980
Several drugs, including clofibrate (ethyl-a-p-chlorophenoxyisobutyrate)1, are now available for the treatment of… (More)
Is this relevant?
1978
1978
Administration of BR-931, an ethanolamine derivative of Wy-14,643 [4-chloro-6-(2,3-xylidino)-2-pyrimidinythio]acetic acid, at a… (More)
Is this relevant?
1978
1978
BR-931 [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio-(N-beta-hydroxyethyl)-acetamide], a new hypolipidemic agent of low toxicity… (More)
Is this relevant?